medroxyprogesterone acetate has been researched along with Adenocarcinoma, Papillary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gumen, A; Keskin, A; Ozyigit, MO; Yilmaz, R; Yilmazbas, G | 1 |
| Matsui, Y; Okudaira, Y; Sawada, M | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Pathological abnormalities after long-term administration of medroxyprogesterone acetate in a queen.
Topics: Adenocarcinoma, Papillary; Animals; Cat Diseases; Cats; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Hysterectomy; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Ovariectomy; Pyometra; Ultrasonography | 2009 |
[Effects of long-term high doses of sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
Topics: Adenocarcinoma, Papillary; Animals; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Uterine Neoplasms | 1985 |